<?xml version="1.0" encoding="UTF-8"?>
<p>
 <xref rid="t0006" ref-type="table">Table 6</xref> displays the symptoms in different animal groups before and after the start of treatment with different formulations. Allergic rhinitis symptoms including nasal irritation and secretions, sneezing, eye secretions and conjunctivitis were found to gradually increase following induction procedures. The total score of the symptoms ranged from 11-12 before the start of treatment (day 1). After 14
 <bold> </bold>days of treatment with the co-loaded loratadine and sulpiride emulsion, these symptoms were significantly reduced (
 <italic>p</italic>
 <bold> </bold>&lt;
 <bold> </bold>.05) displaying a total score of 6. Further reduction of the symptoms was detected after treatment with the co-loaded loratadine and sulpiride nanoemulsion with a total score of 3 (
 <italic>p</italic>
 <bold> </bold>&lt;
 <bold> </bold>.001). On the other hand, Placebo group displayed non-significant reduction of the symptoms with a total score of 9 (
 <italic>p</italic>
 <bold> </bold>&gt;.05).
</p>
